ONO PHARMACEUTICAL CO., LTD.JP:4528Income statement

Market cap
¥1.13T
P/E ratio
15.9x
2012/032013/032014/032015/032016/032017/032018/032019/032020/032021/032022/032023/032024/032025/03
Revenue144,175142,806143,247135,775160,284244,797261,836288,634292,420309,284361,361447,187502,672486,871
Cost of revenue---35,57641,51063,63962,33183,82979,06385,57393,511110,062127,126147,950
Gross profit---99,406117,846179,625197,892204,805213,356223,711267,850337,124375,547338,921
Gross margin (%)---
Operating income -29,94826,42914,79430,50772,28460,68462,01077,49198,330103,195141,963159,93559,747
Operating expenses ---86,46895,212132,515152,35570,03367,67969,23077,05789,486100,270125,671
Income before tax 39,43233,01329,46418,30533,27274,54063,92265,14179,696100,890105,025143,532163,73459,328
Provision for income taxes---3,8916,48114,9208,23313,46219,80825,39224,34030,61935,6949,163
Net income 23,64922,92720,34412,97624,97955,79350,28451,53959,70475,42580,519112,723127,97750,047
Earnings per share44.6143.2538.3824.4847.13105.2797100.25118.47151.11162.19230.85266.61106.55
Diluted EPS----39.1997.2285.6100.24118.45151.09162.16230.79266.57106.41
Dividend payout ratio (%)--------
Dividend per share180180180180180404545455056708080